Comparative analysis of detection performance of novel coronavirus nucleic acid detection reagents.

何绍平 姜亚运 袁成良 刘冬冬
{"title":"Comparative analysis of detection performance of novel coronavirus nucleic acid detection reagents.","authors":"何绍平 姜亚运 袁成良 刘冬冬","doi":"10.3969/j.issn.1009-5519.2021.17.008","DOIUrl":null,"url":null,"abstract":"Objective To evaluate the detection performance of novel coronavirus nucleic acid reagents (Maccura Biological Co.,Ltd,fluorescent PCR method),it is validated clinically and used the same kinds of kits for comparsion research.Methods Compared with novel coronavirus nucleic acid reagents (Shanghai Zhijiang Biological Co.,Ltd,fluorescent PCR method),the similar products of Maccura Biological Co.,Ltd was to be estimated.Pharyngeal swab specimens of 14 COVID-19 patients diagnosed by the CDC and 211 general admission patients from February 18 to 24 were taken into our study,and two kits were used for parallel testing novel coronavirus (ORF1ab/N/E gene).Results The positive rate and negative coincidence rate of Maccura detection kit and Zhijiang' were more than 99.5%.Relative deviation of ORF1ab gene and N gene were not more than ±16%.Conclusion Novel coronavirus nucleic acid detection reagents produced by Maccura Biological Co.,Ltd has good consistency with similar reagents approved for marketing,which can meet the needs of clinical testing. (English) [ABSTRACT FROM AUTHOR] 目的 对迈克生物股份有限公司的新型冠状病毒核酸试剂盒(荧光PCR法)进行临床验证,并 用同类试剂盒进行比对研究。方法 以迈克生物股份有限公司的研发生产的新型冠状病毒核酸检测试剂盒 (荧光PCR法)作为待考核试剂,以上海之江生物科技有限公司的同类产品作为比对试剂。分别对14例由疾控 中心确诊的新型冠状病毒肺炎患者和2020年2月18日至2月24日211例普通入院患者的咽拭子标本进行新 型冠状病毒(ORF1ab/N/E基因)检测,比较两种试剂检测检出率的一致性。结果 迈克新型冠状病毒核酸检 测试剂盒与之江新型冠状病毒核酸检测试剂盒的检测结果阳性率和阴性符合率均达99.5%以上,ORF1ab基 因和N 基因测定值相对偏差不超过±16%。结论 迈克新型冠状病毒核酸检测试剂盒与已获批准上市的同类 试剂检测结果一致性良好,可满足临床检测需求。 (Chinese) [ABSTRACT FROM AUTHOR] Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)","PeriodicalId":64416,"journal":{"name":"现代医药卫生","volume":"37 1","pages":"2909-2911"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"现代医药卫生","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/j.issn.1009-5519.2021.17.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To evaluate the detection performance of novel coronavirus nucleic acid reagents (Maccura Biological Co.,Ltd,fluorescent PCR method),it is validated clinically and used the same kinds of kits for comparsion research.Methods Compared with novel coronavirus nucleic acid reagents (Shanghai Zhijiang Biological Co.,Ltd,fluorescent PCR method),the similar products of Maccura Biological Co.,Ltd was to be estimated.Pharyngeal swab specimens of 14 COVID-19 patients diagnosed by the CDC and 211 general admission patients from February 18 to 24 were taken into our study,and two kits were used for parallel testing novel coronavirus (ORF1ab/N/E gene).Results The positive rate and negative coincidence rate of Maccura detection kit and Zhijiang' were more than 99.5%.Relative deviation of ORF1ab gene and N gene were not more than ±16%.Conclusion Novel coronavirus nucleic acid detection reagents produced by Maccura Biological Co.,Ltd has good consistency with similar reagents approved for marketing,which can meet the needs of clinical testing. (English) [ABSTRACT FROM AUTHOR] 目的 对迈克生物股份有限公司的新型冠状病毒核酸试剂盒(荧光PCR法)进行临床验证,并 用同类试剂盒进行比对研究。方法 以迈克生物股份有限公司的研发生产的新型冠状病毒核酸检测试剂盒 (荧光PCR法)作为待考核试剂,以上海之江生物科技有限公司的同类产品作为比对试剂。分别对14例由疾控 中心确诊的新型冠状病毒肺炎患者和2020年2月18日至2月24日211例普通入院患者的咽拭子标本进行新 型冠状病毒(ORF1ab/N/E基因)检测,比较两种试剂检测检出率的一致性。结果 迈克新型冠状病毒核酸检 测试剂盒与之江新型冠状病毒核酸检测试剂盒的检测结果阳性率和阴性符合率均达99.5%以上,ORF1ab基 因和N 基因测定值相对偏差不超过±16%。结论 迈克新型冠状病毒核酸检测试剂盒与已获批准上市的同类 试剂检测结果一致性良好,可满足临床检测需求。 (Chinese) [ABSTRACT FROM AUTHOR] Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
新型冠状病毒核酸检测试剂检测性能的比较分析。
目的评价新型冠状病毒核酸试剂(麦库拉生物有限公司荧光PCR法)的检测性能,对其进行临床验证,并与同类试剂盒进行对比研究。方法与新型冠状病毒核酸试剂(上海芷江生物有限公司荧光PCR法)进行比较,对麦库拉生物有限公司同类产品进行评价。本研究选取2月18日至24日CDC诊断的14例COVID-19患者和211例普通住院患者咽拭子标本,采用2套试剂盒平行检测新型冠状病毒(ORF1ab/N/E基因)。结果Maccura试剂盒与Zhijiang试剂盒的阳性率和阴性符合率均大于99.5%。ORF1ab基因与N基因的相对偏差不大于±16%。结论麦库拉生物有限公司生产的新型冠状病毒核酸检测试剂与已批准上市的同类试剂具有良好的一致性,能够满足临床检测的需要。从作者(英文)[摘要]目的对迈克生物股份有限公司的新型冠状病毒核酸试剂盒(荧光PCR法)进行临床验证,并用同类试剂盒进行比对研究。方法以迈克生物股份有限公司的研发生产的新型冠状病毒核酸检测试剂盒(荧光PCR法)作为待考核试剂,以上海之江生物科技有限公司的同类产品作为比对试剂。分别对14例由疾控中心确诊的新型冠状病毒肺炎患者和2020年2月18日至2月24日211例普通入院患者的咽拭子标本进行新型冠状病毒(ORF1ab / N / E基因)检测,比较两种试剂检测检出率的一致性。结果迈克新型冠状病毒核酸检测试剂盒与之江新型冠状病毒核酸检测试剂盒的检测结果阳性率和阴性符合率均达99.5%以上,ORF1ab基因和N基因测定值相对偏差不超过±16%。结论 迈克新型冠状病毒核酸检测试剂盒与已获批准上市的同类 试剂检测结果一致性良好,可满足临床检测需求。 【摘要】《现代医学与健康杂志》版权归《现代医学与健康杂志》所有,未经版权所有人书面许可,其内容不得被复制、通过电子邮件发送到多个网站或发布到某个列表服务器。但是,用户可以打印、下载或通过电子邮件发送文章供个人使用。这篇摘要可以删节。对副本的准确性不作任何保证。用户应参考资料的原始出版版本以获取完整摘要。(版权适用于所有摘要。)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
54718
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信